Cassava Sciences Files 8-K: Director Changes, Shareholder Votes, Financials
Ticker: FLNA · Form: 8-K · Filed: May 27, 2025 · CIK: 1069530
| Field | Detail |
|---|---|
| Company | Cassava Sciences INC (FLNA) |
| Form Type | 8-K |
| Filed Date | May 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update, financials
TL;DR
Cassava Sciences 8-K filed: Director/officer changes, shareholder votes, and financials updated. Keep an eye on governance.
AI Summary
Cassava Sciences, Inc. filed an 8-K on May 27, 2025, reporting events as of May 23, 2025. The filing indicates changes related to directors and officers, the submission of matters to a vote of security holders, and financial statements/exhibits. The company, formerly known as Pain Therapeutics Inc., is incorporated in Delaware and operates in the pharmaceutical preparations sector.
Why It Matters
This 8-K filing signals potential shifts in the company's governance and operational reporting, which could impact investor confidence and strategic direction.
Risk Assessment
Risk Level: medium — 8-K filings often contain material information that can lead to stock price volatility, especially those related to director changes or shareholder votes.
Key Numbers
- 001-41905 — SEC File Number (Identifies the company's filing history with the SEC.)
- 911911336 — I.R.S. Employer Identification Number (Company's tax identification number.)
Key Players & Entities
- Cassava Sciences, Inc. (company) — Registrant
- Pain Therapeutics Inc. (company) — Former company name
- May 23, 2025 (date) — Earliest event reported date
- May 27, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
FAQ
What specific changes were made regarding directors or certain officers?
The filing indicates 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers' as an item of report, but the specific details are not provided in this excerpt.
What matters were submitted to a vote of security holders?
The filing lists 'Submission of Matters to a Vote of Security Holders' as an item of report, but the specific matters are not detailed in this excerpt.
What financial statements and exhibits are included in this filing?
The filing notes 'Financial Statements and Exhibits' as an item of report, but the specific contents are not listed in this excerpt.
When was Cassava Sciences, Inc. previously known as?
The company was formerly known as PAIN THERAPEUTICS INC, with a date of name change on March 9, 2000.
What is the primary business of Cassava Sciences, Inc. according to its SIC code?
The company's Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 27, 2025 regarding CASSAVA SCIENCES INC (FLNA).